Faron Pharmaceuticals Oy
LSE:FARN
Faron Pharmaceuticals Oy
Income from Continuing Operations
Faron Pharmaceuticals Oy
Income from Continuing Operations Peer Comparison
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Faron Pharmaceuticals Oy
LSE:FARN
|
Income from Continuing Operations
-€30.9m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
See Also
What is Faron Pharmaceuticals Oy's Income from Continuing Operations?
Income from Continuing Operations
-30.9m
EUR
Based on the financial report for Dec 31, 2023, Faron Pharmaceuticals Oy's Income from Continuing Operations amounts to -30.9m EUR.
What is Faron Pharmaceuticals Oy's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
-9%
Over the last year, the Income from Continuing Operations growth was -8%. The average annual Income from Continuing Operations growth rates for Faron Pharmaceuticals Oy have been -22% over the past three years , -9% over the past five years .